SCHEMBL20111321

SCHEMBL20111321

CCCCc1ccc2c(c1F)-c1c-2cc(O)c(F)c1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.50
HTT P42858 2/20 0.44
TP53 P04637 2/20 0.44
MEN1 O00255 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX5 P09917 1/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ELANE P08246 4/20 0.41
CTSG P08311 4/20 0.41
GCGR P47871 2/20 0.35
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
MAPK1 P28482 2/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NFKB1 P19838 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111275 0.91 HMGCR (0.41) TYRHTTTP53MEN1CYP3A4
SCHEMBL20102401 0.83 TYR (0.41) TYRHTTTP53MEN1CYP3A4
SCHEMBL20102402 0.83 TYR (0.40) TYRHTTTP53MEN1CYP3A4
SCHEMBL20102399 0.79 TYR (0.41) TYRHTTTP53MEN1CYP3A4
SCHEMBL20102400 0.78 TYR (0.43) TYRHTTTP53MEN1CYP3A4
SCHEMBL20111548 0.78 TYR (0.30) TYR
SCHEMBL9419304 0.77 TYR (0.58) TYRHTTTP53MEN1CYP3A4
SCHEMBL20111301 0.77
SCHEMBL20102440 0.77 CTSL (0.40) TYRHTTTP53MEN1CYP3A4
SCHEMBL20102398 0.76 TYR (0.41) TYRHTTTP53MEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S TYR 714/4885HTT 2921/4885TP53 3011/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S TYR 714/4885HTT 2921/4885TP53 3011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.